FOSMANOGEPIX: A Novel Broad-Spectrum Antifungal Agent Being Evaluated in Multiple Clinical Trials – Emerging Insight and Market Forecast to 2030 – ResearchAndMarkets.com December 23, 2020 by Businesswire [#item_full_content] Related Spread the word